NEW research funded by the Heart Foundation aims to boost surgery success rates for life-threatening heart rhythm disorders (arrhythmias), leading to fewer Australians needing defibrillators installed in their chests.
During this World Heart Rhythm Week (05-11 Jun) the focus is on arrhythmias, a life-threatening condition where the heart beats slowly or rapidly.
The causes are varied and procedures (known as 'catheter ablation') are not always successful when scarring is too deep to be reached and treated.
A new study being led by Heart Foundation-funded researcher Dr Pierre Qian (University of Sydney) is aiming to change that.
"A number of arrhythmias commonly occur due to scar tissue formed after a heart attack, which has abnormal properties that can lead to recurring arrhythmias," Qian said.
"Depending on the type of arrhythmia, medications may not always be most suitable, with many patients at high risk receiving an implanted cardiac defibrillator (ICD) which shocks their heart back into a normal rhythm, to prevent sudden death.
"While this saves lives, it commits a growing number of some arrhythmia patients to painful and traumatising defibrillator shocks," Qian said.
As opposed to treating irregular heartbeats with an ICD (where patients can be shocked over and over again), used in the right people, catheter ablation is minimally invasive - and hopefully a one-off procedure where heart scar tissue causing arrhythmias is treated with electrical cautery.
"This procedure uses heat from an electric current to destroy abnormal tissue, however many scars are too deep, which leads to arrhythmias recurring after the surgery.
"I hope my research will lead to improved techniques and outcomes that cure arrhythmias," Dr Qian concluded.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Jun 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Jun 23
